For example, the AXIN1 gene is mutationally inactivated in 5%-19% of HCC tumors, making it the second most frequently mutated gene leading to aberrant Wnt/β-catenin activation in HCC[35,37]. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.